title: Chemokine-based therapies for MS: how do we get there from here?
abstract: The workshop on Multiple Sclerosis and Chemokines: Prospects for Therapeutic and Prophylactic Intervention was held in Chevy Chase, MD, USA, from 9-10 July 2001.
authors.affiliation: Dept of Neurosciences, The Lerner Research Institute, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.
authors.forename: P
authors.initials: P
authors.lastname: Kivisäkk
authors.forename: C
authors.initials: C
authors.lastname: Trebst
authors.forename: D J
authors.initials: DJ
authors.lastname: Eckstein
authors.forename: A P
authors.initials: AP
authors.lastname: Kerza-Kwiatecki
authors.forename: R M
authors.initials: RM
authors.lastname: Ransohoff
mesh_terms: D016564:Amyloid beta-Protein Precursor / Q000031:analogs & derivatives* / Q000378:metabolism; D000818:Animals; D002490:Central Nervous System / Q000276:immunology / Q000473:pathology; D018925:Chemokines / Q000378:metabolism*; D002634:Chemotaxis, Leukocyte; D006801:Humans; D007249:Inflammation / Q000378:metabolism / Q000473:pathology; D007962:Leukocytes / Q000276:immunology; D009103:Multiple Sclerosis / Q000276:immunology / Q000378:metabolism / Q000473:pathology* / Q000628:therapy*; D019707:Receptors, Chemokine / Q000378:metabolism*; D013601:T-Lymphocytes / Q000276:immunology / Q000378:metabolism
chemical_list: C489697:APLP1 protein, human; D016564:Amyloid beta-Protein Precursor; D018925:Chemokines; D019707:Receptors, Chemokine